Loading…

Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes

Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of th...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition and cancer 1999, Vol.33 (1), p.46-52
Main Authors: Hammons, G.J, Fletcher, J.V, Stepps, K.R, Smith, E.A, Balentine, D.A, Harbowy, M.E, Kadlubar, F.F
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33
cites cdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33
container_end_page 52
container_issue 1
container_start_page 46
container_title Nutrition and cancer
container_volume 33
creator Hammons, G.J
Fletcher, J.V
Stepps, K.R
Smith, E.A
Balentine, D.A
Harbowy, M.E
Kadlubar, F.F
description Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection.
doi_str_mv 10.1080/01635589909514747
format article
fullrecord <record><control><sourceid>pubmed_fao_a</sourceid><recordid>TN_cdi_fao_agris_US201302935996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10227043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</originalsourceid><addsrcrecordid>eNqFkN9qFTEQh4Mo9lh9AG80F71dO_m3OQFvpFQtFFrQXi_ZbNKN7CaHJK2eJ-nrmu1WFAr1amB-3zfDDEJvCXwgsIVjIC0TYqsUKEG45PIZ2hDBaCMV4c_RZsmbCpAD9CrnHwAgCdu-RAcEKJXA2QbdnTpnTck4OmxGO8ddiqU2_K3F-tqGJQm4jBbPtug-Tt5gvcS6-BpUa8mMTsaHWPklTvtJzz7YjC_Hs0usw4B5s3Ri73ejDfsJ-4DHm1mH-zDpgqe6MOHZmxRznG1-jV44PWX75qEeoqvPp99PvjbnF1_OTj6dN4YLUhpHnTN2MG1rjLKWEKO0ECA5GCoGkALo1gxUcaeJklaB7Q0oxSnhjPU9Y4eIrHOXxTlZ1-2Sn-sJHYFueXL36MnVebc6u5t-tsM_xvrVChw9ADobPbmkg_H5LyfbVohljlwxH1xMs_4Z0zR0Re-nmP44j7Z35Vep5sf_muypA96vutOx09ep0lffKBAGVDGhVMt-AxVUtY8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Hammons, G.J ; Fletcher, J.V ; Stepps, K.R ; Smith, E.A ; Balentine, D.A ; Harbowy, M.E ; Kadlubar, F.F</creator><creatorcontrib>Hammons, G.J ; Fletcher, J.V ; Stepps, K.R ; Smith, E.A ; Balentine, D.A ; Harbowy, M.E ; Kadlubar, F.F</creatorcontrib><description>Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection.</description><identifier>ISSN: 0163-5581</identifier><identifier>EISSN: 1532-7914</identifier><identifier>DOI: 10.1080/01635589909514747</identifier><identifier>PMID: 10227043</identifier><identifier>CODEN: NUCADQ</identifier><language>eng</language><publisher>Philadelphia, PA: Taylor &amp; Francis Group</publisher><subject>amines ; Aminobiphenyl Compounds - metabolism ; animal models ; Animals ; Anticarcinogenic Agents - pharmacology ; antineoplastic agents ; Antioxidants - pharmacology ; aromatic compounds ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; carcinogens ; Carcinogens - metabolism ; Diterpenes - pharmacology ; Estrogens, Non-Steroidal - pharmacology ; Flavonoids - pharmacology ; Foods and miscellaneous ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Imidazoles - metabolism ; inhibition ; Isoflavones ; liver ; Liver Neoplasms - chemically induced ; Liver Neoplasms - metabolism ; Liver Neoplasms - prevention &amp; control ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; microsomes ; Microsomes, Liver - drug effects ; Microsomes, Liver - metabolism ; Phenols - pharmacology ; Phytoestrogens ; Plant Preparations ; Polymers - pharmacology ; Rats ; Rats, Inbred F344 ; Tumors</subject><ispartof>Nutrition and cancer, 1999, Vol.33 (1), p.46-52</ispartof><rights>Copyright Taylor &amp; Francis Group, LLC 1999</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</citedby><cites>FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1766557$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10227043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hammons, G.J</creatorcontrib><creatorcontrib>Fletcher, J.V</creatorcontrib><creatorcontrib>Stepps, K.R</creatorcontrib><creatorcontrib>Smith, E.A</creatorcontrib><creatorcontrib>Balentine, D.A</creatorcontrib><creatorcontrib>Harbowy, M.E</creatorcontrib><creatorcontrib>Kadlubar, F.F</creatorcontrib><title>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</title><title>Nutrition and cancer</title><addtitle>Nutr Cancer</addtitle><description>Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection.</description><subject>amines</subject><subject>Aminobiphenyl Compounds - metabolism</subject><subject>animal models</subject><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>antineoplastic agents</subject><subject>Antioxidants - pharmacology</subject><subject>aromatic compounds</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>carcinogens</subject><subject>Carcinogens - metabolism</subject><subject>Diterpenes - pharmacology</subject><subject>Estrogens, Non-Steroidal - pharmacology</subject><subject>Flavonoids - pharmacology</subject><subject>Foods and miscellaneous</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Imidazoles - metabolism</subject><subject>inhibition</subject><subject>Isoflavones</subject><subject>liver</subject><subject>Liver Neoplasms - chemically induced</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - prevention &amp; control</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>microsomes</subject><subject>Microsomes, Liver - drug effects</subject><subject>Microsomes, Liver - metabolism</subject><subject>Phenols - pharmacology</subject><subject>Phytoestrogens</subject><subject>Plant Preparations</subject><subject>Polymers - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Tumors</subject><issn>0163-5581</issn><issn>1532-7914</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkN9qFTEQh4Mo9lh9AG80F71dO_m3OQFvpFQtFFrQXi_ZbNKN7CaHJK2eJ-nrmu1WFAr1amB-3zfDDEJvCXwgsIVjIC0TYqsUKEG45PIZ2hDBaCMV4c_RZsmbCpAD9CrnHwAgCdu-RAcEKJXA2QbdnTpnTck4OmxGO8ddiqU2_K3F-tqGJQm4jBbPtug-Tt5gvcS6-BpUa8mMTsaHWPklTvtJzz7YjC_Hs0usw4B5s3Ri73ejDfsJ-4DHm1mH-zDpgqe6MOHZmxRznG1-jV44PWX75qEeoqvPp99PvjbnF1_OTj6dN4YLUhpHnTN2MG1rjLKWEKO0ECA5GCoGkALo1gxUcaeJklaB7Q0oxSnhjPU9Y4eIrHOXxTlZ1-2Sn-sJHYFueXL36MnVebc6u5t-tsM_xvrVChw9ADobPbmkg_H5LyfbVohljlwxH1xMs_4Z0zR0Re-nmP44j7Z35Vep5sf_muypA96vutOx09ep0lffKBAGVDGhVMt-AxVUtY8</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>Hammons, G.J</creator><creator>Fletcher, J.V</creator><creator>Stepps, K.R</creator><creator>Smith, E.A</creator><creator>Balentine, D.A</creator><creator>Harbowy, M.E</creator><creator>Kadlubar, F.F</creator><general>Taylor &amp; Francis Group</general><general>Taylor&amp; Francis</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1999</creationdate><title>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</title><author>Hammons, G.J ; Fletcher, J.V ; Stepps, K.R ; Smith, E.A ; Balentine, D.A ; Harbowy, M.E ; Kadlubar, F.F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>amines</topic><topic>Aminobiphenyl Compounds - metabolism</topic><topic>animal models</topic><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>antineoplastic agents</topic><topic>Antioxidants - pharmacology</topic><topic>aromatic compounds</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>carcinogens</topic><topic>Carcinogens - metabolism</topic><topic>Diterpenes - pharmacology</topic><topic>Estrogens, Non-Steroidal - pharmacology</topic><topic>Flavonoids - pharmacology</topic><topic>Foods and miscellaneous</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Imidazoles - metabolism</topic><topic>inhibition</topic><topic>Isoflavones</topic><topic>liver</topic><topic>Liver Neoplasms - chemically induced</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - prevention &amp; control</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>microsomes</topic><topic>Microsomes, Liver - drug effects</topic><topic>Microsomes, Liver - metabolism</topic><topic>Phenols - pharmacology</topic><topic>Phytoestrogens</topic><topic>Plant Preparations</topic><topic>Polymers - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammons, G.J</creatorcontrib><creatorcontrib>Fletcher, J.V</creatorcontrib><creatorcontrib>Stepps, K.R</creatorcontrib><creatorcontrib>Smith, E.A</creatorcontrib><creatorcontrib>Balentine, D.A</creatorcontrib><creatorcontrib>Harbowy, M.E</creatorcontrib><creatorcontrib>Kadlubar, F.F</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nutrition and cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammons, G.J</au><au>Fletcher, J.V</au><au>Stepps, K.R</au><au>Smith, E.A</au><au>Balentine, D.A</au><au>Harbowy, M.E</au><au>Kadlubar, F.F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes</atitle><jtitle>Nutrition and cancer</jtitle><addtitle>Nutr Cancer</addtitle><date>1999</date><risdate>1999</risdate><volume>33</volume><issue>1</issue><spage>46</spage><epage>52</epage><pages>46-52</pages><issn>0163-5581</issn><eissn>1532-7914</eissn><coden>NUCADQ</coden><abstract>Carcinogenic aromatic amines, including the heterocyclic amines, may pose a significant health risk to humans. To determine the potential for chemoprotective intervention against the carcinogenicity of these arylamines and to better understand their mechanism of action, a range of agents, most of them natural dietary constituents, was examined in vitro for their ability to modulate the N-hydroxylation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 4-aminobiphenyl (ABP), an initial step in their bioactivation. Experiments were conducted with rat and human liver microsomes. The agents (diallyl sulfide, indole-3-carbinol, alpha-angelicalactone, cafestol/kahweol palmitates, cafestol, kahweol, benzylisothiocyanate, genistin, formononetin, daidzin, equol, biochanin A, Oltipraz, tannic acid, quercetin, ethoxyquin, green tea, and black tea) comprised a variety of chemical classes that included sulfur-containing compounds, antioxidants, flavonoids, phytoestrogens, diterpenes, and polyphenols. Several of these agents, quercetin, ethoxyquin, and black tea, were found to strongly inhibit PhIP N-hydroxylation in rat liver microsomes, resulting in a nearly 85-90% decrease in activity at 100 micromolar or 0.2%. Tannic acid and green tea, in addition to these agents, were also strong inhibitors of ABP N-hydroxylation. In human liver microsomes, each of these agents was strongly inhibitory (approx 85-95% at 100 micromolar or 0.02%) of PhIP and ABP N-hydroxylation. Theaflavins and polyphenols were judged to be the primary inhibiting components in the teas, the theaflavins showing the most potent effect. These results demonstrate that chemoprotective agents can inhibit the bioactivation of carcinogenic arylamines, and this is likely to be one of the mechanisms of protection.</abstract><cop>Philadelphia, PA</cop><pub>Taylor &amp; Francis Group</pub><pmid>10227043</pmid><doi>10.1080/01635589909514747</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-5581
ispartof Nutrition and cancer, 1999, Vol.33 (1), p.46-52
issn 0163-5581
1532-7914
language eng
recordid cdi_fao_agris_US201302935996
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects amines
Aminobiphenyl Compounds - metabolism
animal models
Animals
Anticarcinogenic Agents - pharmacology
antineoplastic agents
Antioxidants - pharmacology
aromatic compounds
Biological and medical sciences
Carcinogenesis, carcinogens and anticarcinogens
carcinogens
Carcinogens - metabolism
Diterpenes - pharmacology
Estrogens, Non-Steroidal - pharmacology
Flavonoids - pharmacology
Foods and miscellaneous
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Imidazoles - metabolism
inhibition
Isoflavones
liver
Liver Neoplasms - chemically induced
Liver Neoplasms - metabolism
Liver Neoplasms - prevention & control
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
microsomes
Microsomes, Liver - drug effects
Microsomes, Liver - metabolism
Phenols - pharmacology
Phytoestrogens
Plant Preparations
Polymers - pharmacology
Rats
Rats, Inbred F344
Tumors
title Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T05%3A46%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_fao_a&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20chemoprotective%20agents%20on%20the%20metabolic%20activation%20of%20the%20carcinogenic%20arylamines%20PhIP%20and%204-aminobiphenyl%20in%20human%20and%20rat%20liver%20microsomes&rft.jtitle=Nutrition%20and%20cancer&rft.au=Hammons,%20G.J&rft.date=1999&rft.volume=33&rft.issue=1&rft.spage=46&rft.epage=52&rft.pages=46-52&rft.issn=0163-5581&rft.eissn=1532-7914&rft.coden=NUCADQ&rft_id=info:doi/10.1080/01635589909514747&rft_dat=%3Cpubmed_fao_a%3E10227043%3C/pubmed_fao_a%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-f2ffcedc66cc9ee11c9a550740c25d075028cd294fa197e90ebc099421433bb33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10227043&rfr_iscdi=true